20/08/2026
New Huntington’s disease (HD) trial begins! A Phase 1 study is testing SRP-1005, a huntingtin-lowering therapy given by injection under the skin. It’s early days, but this approach could add an important new arrow to the HD drug development quiver.
More details in this article: https://en.hdbuzz.net/a-shot-in-the-arm-for-htt-lowering-insightt-trial-begins-testing-srp-1005/